A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
The Fed Won’t Talk About Rate Cuts. Why Traders Are Betting on Them.
2023-11-28 19:45
A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
You Might Like...
Charli D'Amelio: Why TikTok star had to bear brunt of enraged F1 fans?
Android users can now get alerts for unknown AirTags
Robbie Williams wanted to be in FIFA so much, he apparently would have passed up the paycheck
Andrew Tate: Marvin Vettori hails 'toxic' influencer after fiery BBC interview, calls him 'genius'
Brazil soccer star Neymar fined $3.5 million for environmental offense
Get these JBL wireless earbuds for 62% off
ChatGPT's app for iOS is now available in the UK and 10 more countries
Google AI-powered search gets better at citing its sources